Q2 2025 Danaher Corp Earnings Call Transcript
Key Points
- Danaher Corp (DHR) reported strong execution with the Danaher Business System, driving solid second-quarter results despite a dynamic operating environment.
- The bioprocessing business showed strong growth, with low double-digit growth in consumables driven by commercial demand and large Pharma CDMO customers.
- Adjusted diluted net earnings per common share increased by approximately 5% year over year, reaching $1.80.
- Danaher Corp (DHR) generated $1.1 billion of free cash flow in the quarter, with a year-to-date free cash flow to net income conversion ratio of 143%.
- The company launched several important new products and technologies, reinforcing its long-term competitive position and delivering meaningful benefits to customers.
- Global trade tensions and tariffs have created uncertainty, impacting larger capital investment decisions and delaying some orders.
- Core revenue in the Life Sciences segment decreased by 2.5%, with declines in life sciences instrument businesses and genomics consumables.
- The Diagnostics segment faced challenges in China due to volume-based procurement and reimbursement changes, leading to a mid-single-digit decline.
- The macro environment remains fluid, with ongoing uncertainty around research funding affecting academic and government demand.
- Bioprocessing equipment revenue remains below historical trends, with global trade uncertainty contributing to delays in larger capital investment decisions.
(Operator Instructions)
My name is Margo, and I'll be your conference facilitator this morning. At this time, I'd like to welcome everyone to Danaher Corporation's second-quarter 2025 earnings results conference call.
(Operator Instructions)
I will now turn the call over to John Bedford, Vice President of Investor Relations. Mr. Bedford, you may begin your conference.
(technical difficulty) and required by SEC Regulation G relating to any non-GAAP financial measures provided during the call and a note containing details of historical and anticipated future financial performance are all available on the Investors section of our website, www.danaher.com, under the heading Quarterly Earnings.
The audio portion of this call will be archived on the Investors section of our website later today under the heading Events and Presentations and will remain archived until our next quarterly call. A replay of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
